nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of the validity of a population pharmacokinetic model for epirubicin
|
Ralph, Lorraine D. |
|
2006 |
62 |
1 |
p. 47-55 |
artikel |
2 |
Cancer pharmacotherapy: 21st century ‘magic bullets’ and changing paradigms
|
Lewis, L. D. |
|
2006 |
62 |
1 |
p. 1-4 |
artikel |
3 |
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
|
Joerger, M. |
|
2006 |
62 |
1 |
p. 71-80 |
artikel |
4 |
Drug development in oncology: classical cytotoxics and molecularly targeted agents
|
Kummar, Shivaani |
|
2006 |
62 |
1 |
p. 15-26 |
artikel |
5 |
New targets and challenges in the molecular therapeutics of cancer
|
Eastman, Alan |
|
2006 |
62 |
1 |
p. 5-14 |
artikel |
6 |
Paracetamol use and risk of ovarian cancer: a meta-analysis
|
Bonovas, Stefanos |
|
2006 |
62 |
1 |
p. 113-121 |
artikel |
7 |
Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group study
|
Mould, Diane R. |
|
2006 |
62 |
1 |
p. 56-70 |
artikel |
8 |
Population pharmacokinetics of imatinib and the role of α1-acid glycoprotein
|
Widmer, N. |
|
2006 |
62 |
1 |
p. 97-112 |
artikel |
9 |
Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients
|
Perez-Ruixo, Juan Jose |
|
2006 |
62 |
1 |
p. 81-96 |
artikel |
10 |
Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy
|
Boddy, Alan V. |
|
2006 |
62 |
1 |
p. 27-34 |
artikel |
11 |
Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region
|
Chinellato, Alessandro |
|
2006 |
62 |
1 |
p. 130-133 |
artikel |
12 |
The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and β-glucuronidase in human colorectal tumours
|
Tobin, Peter |
|
2006 |
62 |
1 |
p. 122-129 |
artikel |
13 |
The role of pharmacogenetics in cancer therapeutics
|
Yong, Wei Peng |
|
2006 |
62 |
1 |
p. 35-46 |
artikel |